Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.

Zhou SL, Ku JW, Fan ZM, Yue WB, Du F, Zhou YF, Liu YL, Li Y, Tang S, Hu YL, Hu XP, Hou ZC, Liu J, Liu Y, Feng XS, Wang LD.

Dis Esophagus. 2015 May-Jun;28(4):371-9. doi: 10.1111/dote.12206. Epub 2014 Mar 10.

PMID:
24612004
2.

Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.

Zhou SL, Yue WB, Fan ZM, Du F, Liu BC, Li B, Han XN, Ku JW, Zhao XK, Zhang P, Cui J, Zhou FY, Zhang LQ, Fan XP, Zhou YF, Zhu LL, Liu HY, Wang LD.

Dis Esophagus. 2014 Nov-Dec;27(8):790-7. doi: 10.1111/dote.12145. Epub 2013 Oct 21.

PMID:
24147952
3.

Evaluation of tumour-associated antigen (TAA) miniarray in immunodiagnosis of colon cancer.

Liu W, Wang P, Li Z, Xu W, Dai L, Wang K, Zhang J.

Scand J Immunol. 2009 Jan;69(1):57-63. doi: 10.1111/j.1365-3083.2008.02195.x.

4.

Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.

Li J, Wang LJ, Ying X, Han SX, Bai E, Zhang Y, Zhu Q.

Scand J Immunol. 2012 Mar;75(3):342-9. doi: 10.1111/j.1365-3083.2011.02657.x.

5.

Evaluation of diagnostic value in using a panel of multiple tumor-associated antigens for immunodiagnosis of cancer.

Wang P, Song C, Xie W, Ye H, Wang K, Dai L, Zhang Y, Zhang J.

J Immunol Res. 2014;2014:512540. doi: 10.1155/2014/512540. Epub 2014 Apr 13.

6.

Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.

Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK.

J Hepatol. 2007 Jan;46(1):107-14. Epub 2006 Sep 25.

7.

Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.

Qin JJ, Wang XR, Wang P, Ren PF, Shi JX, Zhang HF, Xia JF, Wang KJ, Song CH, Dai LP, Zhang JY.

Asian Pac J Cancer Prev. 2014;15(6):2635-40.

8.

Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.

Liu W, De La Torre IG, Gutiérrez-Rivera MC, Wang B, Liu Y, Dai L, Qian W, Zhang JY.

Tumour Biol. 2015 Feb;36(2):1307-12. doi: 10.1007/s13277-014-2756-5. Epub 2014 Oct 30.

PMID:
25355596
9.

Autoantibodies against tumor-associated antigens in the early detection of lung cancer.

Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY.

Lung Cancer. 2016 Sep;99:172-9. doi: 10.1016/j.lungcan.2016.07.018. Epub 2016 Jul 18.

PMID:
27565936
10.

Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.

Li P, Shi JX, Xing MT, Dai LP, Li JT, Zhang JY.

Tumour Biol. 2017 Oct;39(10):1010428317711662. doi: 10.1177/1010428317711662.

PMID:
29022480
11.

Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

Zhang JY, Casiano CA, Peng XX, Koziol JA, Chan EK, Tan EM.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):136-43.

12.
13.

Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.

Hoshino I, Nagata M, Takiguchi N, Nabeya Y, Ikeda A, Yokoi S, Kuwajima A, Tagawa M, Matsushita K, Satoshi Y, Hideaki S.

Cancer Sci. 2017 Mar;108(3):308-315. doi: 10.1111/cas.13158.

14.

A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.

Huangfu M, Xu S, Li S, Sun B, Lee KH, Liu L, Sun S.

Tumour Biol. 2016 Jul;37(7):8709-14. doi: 10.1007/s13277-015-4472-1. Epub 2016 Jan 6.

PMID:
26738866
15.

Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.

Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, Qiu SL, Yang CS.

Int J Cancer. 1994 Nov 15;59(4):514-9.

PMID:
7960222
16.

Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer.

Ye H, Sun C, Ren P, Dai L, Peng B, Wang K, Qian W, Zhang J.

Oncol Lett. 2013 Feb;5(2):663-668. Epub 2012 Dec 5.

17.

Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.

Dai L, Li J, Ortega R, Qian W, Casiano CA, Zhang JY.

J Immunol Res. 2014;2014:827827. doi: 10.1155/2014/827827. Epub 2014 Apr 17.

18.

Tumor-associated autoantibody signature for the early detection of gastric cancer.

Zayakin P, Ancāns G, Siliņa K, Meistere I, Kalniņa Z, Andrejeva D, Endzeliņš E, Ivanova L, Pismennaja A, Ruskule A, Doniņa S, Wex T, Malfertheiner P, Leja M, Linē A.

Int J Cancer. 2013 Jan 1;132(1):137-47. doi: 10.1002/ijc.27667. Epub 2012 Jul 3.

19.

Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.

Sun H, Shi JX, Zhang HF, Xing MT, Li P, Dai LP, Luo CL, Wang X, Wang P, Ye H, Li LX, Zhang JY.

Tumour Biol. 2017 Jun;39(6):1010428317699132. doi: 10.1177/1010428317699132.

PMID:
28618923
20.

Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.

Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY.

Clin Immunol. 2014 May-Jun;152(1-2):127-39. doi: 10.1016/j.clim.2014.03.007. Epub 2014 Mar 22.

Supplemental Content

Support Center